Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Hudbay Exploration Review Webcast

<< Previous

Bullboard Posts

Next >>

Comment by guerreiroon Dec 22, 2010 5:52pm

180 Views

Post# 17885407

RE: Hudbay Exploration Review Webcast

Thanks The 300.
You seem to be close to the picture!!! May I ask you a question ??? !!!. How close Is HLO to closing its PP and what is the holdup. If the insiders are having trouble coming up with the money for the PP; I will be glad to participate.; Perhaps I should D & D Securities and ask if they need help on such cheap financing. Another possibility of the holdup is the application for cheap options for insiders or for possible new appointed Directors.

HLO, sure looks inviting on the chart such a beatiful pattern, perhaps news is near, Santa will bring it before Christmas. and 2011 buckle your seat belts.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver